Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.46 |
| ▸ | HTR2A | P28223 | 3/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9769538 | 0.98 | TAAR1 (0.45) | TAAR1HTR2ACHRNB2CHRNA4DPP4 | |
| SCHEMBL29173019 | 0.81 | TAAR1 (0.33) | TAAR1HTR2ALMNA | |
| SCHEMBL19292352 | 0.78 | LMNA (0.48) | TAAR1HTR2ADPP4F2LMNA | |
| SCHEMBL4631655 | 0.77 | DPP4 (0.44) | TAAR1HTR2ADPP4F2LMNA | |
| SCHEMBL19165393 | 0.75 | LMNA (0.48) | TAAR1DPP4F2LMNA | |
| SCHEMBL19711876 | 0.75 | LMNA (0.48) | TAAR1DPP4F2LMNA | |
| SCHEMBL9602487 | 0.74 | CSNK1E (0.47) | HTR2ALMNA | |
| Hydrochloric Acid SCHEMBL9147182 | 0.73 | ALDH1A1 (0.50) | TAAR1DPP4F2LMNA | |
| SCHEMBL19233902 | 0.72 | TAAR1 (0.52) | TAAR1HTR2ACHRNB2CHRNA4DPP4 | |
| SCHEMBL4553372 | 0.72 | TAAR1 (0.52) | TAAR1HTR2ACHRNB2CHRNA4DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0451753-A1 | In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines | ASTA Medica Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | claimed |
| CN-111269163-B | Method for removing gamma butyrolactone in N-methyl pyrrolidone | 江苏盈天环保科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-11026419-B2 | Silver- and copper-chelating ionic liquids, polymers, and gels, and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-08 | — | — | US | disclosed |
| CN-111269163-A | Method for removing gamma butyrolactone in N-methyl pyrrolidone | 江苏盈天化学有限公司 | 2020-06-12 | — | — | CN | disclosed |
| US-20190327964-A1 | SILVER- AND COPPER-CHELATING IONIC LIQUIDS, POLYMERS, AND GELS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2019-10-31 | — | — | US | disclosed |
| US-5238955-A | Anticarcinogenic agents | ASTA PHARMA AG (DE) | 1993-08-24 | — | — | US | disclosed |
| US-5238955-A | Anticarcinogenic agents | ASTA PHARMA AG (DE) | 1993-08-24 | — | — | US | disclosed |
| US-5194644-A | Antitumor agents; treatment of leukemia | ASTA PHARMA AG (DE) | 1993-03-16 | — | — | US | disclosed |
| EP-0451753-A1 | In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines | ASTA Medica Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| US-4885327-A | REACTION PRODUCT OF POLYVINYLBENZYL HALIDE WITH AMINE; DETOXIFICATION | SOUTHWEST RESEARCH INSTITUTE (US) | 1989-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11026419-B2 | Silver- and copper-chelating ionic liquids, polymers, and gels, and uses thereof | SOD1, AOC1, SOD3 | TAAR1 3417/4885HTR2A 4832/4885CHRNB2 4880/4885 |
| US-20190327964-A1 | SILVER- AND COPPER-CHELATING IONIC LIQUIDS, POLYMERS, AND GELS, AND USES THEREOF | SOD1, AOC1, SOD3 | TAAR1 3417/4885HTR2A 4832/4885CHRNB2 4880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.